Patent ID: 9345770
Filing Date: 2016-05-24
CPC Classification: A61K,A61P,C12N,G01N

Claim Text:
1. A method for eliciting an immune response to a tumor in a subject, comprising administering to a subject a therapeutically effective amount of a composition comprising a plurality of polypeptides, wherein each polypeptide in the plurality is at most twelve amino acids in length, wherein the plurality of polypeptides comprises: (a) a Protein Delta Homolog 1 (DLK1) polypeptide comprising the amino acid sequence set forth as ILGVLTSLV (SEQ ID NO: 2); (b) a Neuropilin 1 (NRP1) polypeptide comprising the amino acid sequence set forth as GX (c) a Tumor Endothelial Marker 1 (TEM1) polypeptide comprising the amino acid sequence set forth as LLVPTCVFX thereby eliciting the immune response to the tumor in the subject, wherein the tumor expresses DLK1, NRP1 and TEM1.